Viewing nowDonepezil 10 mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 200605447 · Notified 2006.05.30 · Insurance code 643500330
Treatment of symptoms of Alzheimer-type dementia
This medication is used for the treatment of symptoms of Alzheimer's type dementia.
○ Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, morning administration of this drug may be considered. Because donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with attention to gastrointestinal adverse reactions. If administration of this drug is discontinued, its effects gradually diminish; no rebound effect occurs with abrupt discontinuation. ○ Female patients aged 85 years or older with low body weight: Because adverse reactions occur frequently, careful monitoring is required. Elderly women with low body weight should not exceed 5 mg daily.
No experience of use in pediatric patients.
This medication contains Donepezil Hydrochloride Hydrate as its active ingredient and is used for the improvement of symptoms in patients with Alzheimer's type dementia. This medication should not be administered to patients with hypersensitivity to specific ingredients, pregnant women or nursing mothers, or patients with lactose intolerance or genetic lactose metabolism disorders. Patients with heart disease should use this medication with caution, as it may slow down heart rate or induce arrhythmias, and patients with a history of gastric ulcers or who are taking non-steroidal anti-inflammatory drugs should also be cautious. Patients with a history of asthma or obstructive pulmonary diseases should use this medication carefully, as it may induce bronchoconstriction or worsen symptoms. Caution should be exercised in patients with extrapyramidal disorders such as Parkinson's disease, as this medication may worsen symptoms. During the use of this medication, serious side effects such as syncope, bradycardia, heart block, peptic ulcer, liver dysfunction, seizures, muscular symptoms, etc., may occur, so immediate consultation with healthcare professionals is required if such symptoms appear. Common side effects may include nausea, vomiting, diarrhea, decreased appetite, dizziness, insomnia, headache, and fatigue, most of which are temporary and mild. This medication requires special caution in patients with cardiac conduction disorders or prolonged QT intervals, as the risk of side effects may increase when used in combination with heart-related medications. Additionally, as this medication is metabolized by certain liver enzymes (CYP3A4, CYP2D6), drug effects may change when used in conjunction with other medications that inhibit or induce these enzymes, so patients should inform their healthcare provider of any concomitant medications. Pregnant or nursing women are advised not to use this medication unless absolutely necessary and under the supervision of a healthcare professional. Safety in pediatric patients has not been established, so this medication is not to be used in children. Patients should be cautious about dizziness or fatigue while driving or operating machinery during the use of this medication. In case of overdose, severe symptoms such as nausea, vomiting, significant muscle weakness, and difficulty breathing may occur, which requires immediate medical attention; atropine may be used as an antidote. This medication should be stored out of reach of children, and it is safe not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.